Financial health equity. Intervention for balance and financial stability of national health providing institutions, , health promoters and insurers.
*Itzjak Kadar, University professor 

Keywords: Equity, health economics, health policies, high costs, reform

Background: A better or worse health systems are measured and influenced by the most limiting factors such as access, timeliness, coverage and equity in service to the population. France known for his good health system, as the country that spent on health per person in us $ 4056 per year equivalent to 11.1% of gross domestic product in which has the highest life expectancy with 81, in the other side the Republic of Congo with an investment of just $ 42 per year, corresponding to 2.1% of GDP with a life expectancy of only 54 years. (WHO 2006, table 1) These investments constitute a limit for health management , in developing countries have a very limited amount to beforcing production more efficiently and effectively using the few resources that have for handling each health system.

Objectives: • Achieve an efficient cost-effective management. • Rewarding healthcare companies who work toward prevention and reduce the prevalence of diseases that generate high costs, reducing spending generated by the advanced stages of preventable diseases. Methods: Develop standardized guidelines for the management of diseases with evidence-based scientific rigor and an acceptable cost. Develop a monitoring system in management of health care promoting , insurance companies and health service institutions (like hospitals) use on disease prevention and control of risk factors that finally generate high costs. Also, analyze the results to generate internal policies.

Results: Building financial stability for all companies that comply with health prevention policies mentioned before, delivering a budget increase for those health care promoting companies whose load of with high-cost patients, exceeds the standard deviation and decrease the budget for those who have reduced load.

This will reward only those companies who have a good intervention and prevention proceeds that has reduced load of these diseases through the time